TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Merck Life Science AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 883,906 | 675,676 | 552,976 |
Financial expenses | 819 | 22 | 51 |
Earnings before taxes | 475,135 | 448,792 | 351,203 |
EBITDA | 472,667 | 448,735 | 351,229 |
Total assets | 613,179 | 419,610 | 449,247 |
Current assets | 603,301 | 364,597 | 397,413 |
Current liabilities | 88,958 | 49,047 | 49,927 |
Equity capital | 516,998 | 366,188 | 398,068 |
- share capital | 6,883 | 7,489 | 7,634 |
Employees (average) | 46 | 29 | 29 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 84.3% | 87.3% | 88.6% |
Turnover per employee | 19,215 | 23,299 | 19,068 |
Profit as a percentage of turnover | 53.8% | 66.4% | 63.5% |
Return on assets (ROA) | 77.6% | 107.0% | 78.2% |
Current ratio | 678.2% | 743.4% | 796.0% |
Return on equity (ROE) | 91.9% | 122.6% | 88.2% |
Change turnover | 262,960 | 133,168 | 41,290 |
Change turnover % | 42% | 25% | 8% |
Chg. No. of employees | 17 | 0 | 1 |
Chg. No. of employees % | 59% | 0% | 4% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.